2017   2016   2015   2014   2013   2012   2011   2010   2009   2008  

02. November 2008
Meet Zedira at MEDICA in November 2008
Document

01. November 2008
Meet Zedira at BIO-Europe in November 2008
Document

03. September 2008
Sanofi-Aventis names Zedira as supplier for R&D products in September 2008
Document

02. September 2008
Structure of inhibited tissue transglutaminase published at XXth International Symposium on Medicinal Chemistry in September 2008
Document

02. September 2008
What Links Celiac Disease, Thrombosis, Skin and Hair? (Article in lab&more September 2008)
Document

08. August 2008
Novo Nordisk names Zedira as supplier for R&D products in August 2008
Document

03. June 2008
Zedira launches TG6 In Vitro Diagnostic (IVD) in June 2008
Document

01. April 2008
Transglutaminase Newsletter April 2008
Document

  • News  

    • Press release: Dr. Falk Pharma and Zedira announce completion of phase 1b clinical trial of ZED1227 for the treatment of celiac disease and move on to proof of concept study
    • Pressemitteilung: Dr. Falk Pharma und Zedira geben den Abschluss der Phase 1b-Studie für ZED1227 zur Zöliakie-Therapie bekannt und planen Start der Wirksamkeitsstudie
  • Blog

  • Events  

    • 17th International Celiac Disease Symposium

      08.09.2017 - 10.09.2017
      New Delhi, India

    • NLSDays 2017

      12.09.2017 - 14.09.2017
      Malmö, Sweden

    • BIO-Europe

      06.11.2017 - 08.11.2017
      Berlin, Germany

    • MEDICA

      13.11.2017 - 16.11.2017
      Düsseldorf, Germany

    • Gordon Research Conference on: Transglutaminases in Human Disease Processes

      16.06.2018 - 17.06.2018
      Les Diablerets, Switzerland